Magenta Therapeutics
1 MGTA 145 in Combination with Plerixafor Rapidly Mobilizes Large Numbers of HSCs in Humans That Can Be Gene Edited with CRISPRCas9 and Mediate Superior Engraftment to Standard of Care Kev
Embed this Presentation
Available Downloads
Download Notice
Download Presentation The PPT/PDF document "Magenta Therapeutics" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.